Global pharma network Patheon operates across 65+ locations worldwide with capabilities spanning API, biologics, viral vectors, formulation, clinical trial services, logistics, and commercial manufacturing, presenting cross-region selling opportunities and integrated solutions for pharma customers.

Expansion and partnerships Recent and ongoing collaborations and facility expansions (e.g., Mebane expansion, Ethris integration, Cybin partnerships, RoosterBio collaboration) indicate a growth trajectory and appetite for outsourcing, enabling proactive outreach to potential clients seeking scalable manufacturing and development partnerships.

PharmaFlex platform Launch of PharmaFlex a flexible manufacturing platform for biologics small molecules and complex formulations signals a selling point for clients needing adaptable capacity and speed-to-market, particularly in early-phase to late-stage programs.

Digital enablement Investments in digital tools like the mySupply platform and Pharma 4.0 enable real-time data visibility, which can be leveraged to address clients’ supply chain transparency, risk management, and accelerated decision-making requirements.

Financial scale and capability With revenue in the multiple hundreds of millions to a billion-plus range and a strong services portfolio, there is an opportunity to target mid to large biotech and pharma companies seeking integrated development to commercialization outsourcing with global logistics and regulatory support.